Pricing Log in Create free account

CytomX Therapeutics, Inc. (CTMX) vs Ceryvyn Therapeutics Ltd. - Unsponsored ADR (CYVNY)

CytomX Therapeutics, Inc. and Ceryvyn Therapeutics Ltd. - Unsponsored ADR are both Biotechnology companies. CytomX Therapeutics, Inc. and Ceryvyn Therapeutics Ltd. - Unsponsored ADR are of similar size ($525.1M and $524.8M). CytomX Therapeutics, Inc. has the higher net margin (−451.6% vs −89,724.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, CytomX Therapeutics, Inc. leads on 7 and Ceryvyn Therapeutics Ltd. - Unsponsored ADR on 7.

Valuation

Metric CTMX CYVNY Biotechnology median
P/E n/m n/m 8.50
P/S 27.16 2.37 9.71
P/B 1.65 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 9.28 759.28 9.21
Earnings yield (22.03%) (2,375.00%) (33.15%)
Free cash flow yield (16.63%) (84,379.36%) (25.50%)

Profitability

Metric CTMX CYVNY Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (476.19%) 0.00% 0.00%
Net margin (451.62%) (89,724.18%) 0.00%
Free cash flow margin (450.27%) 0.00% 0.00%
Return on equity (39.18%) 0.00% (56.36%)
Return on assets (29.72%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CTMX CYVNY Biotechnology median
Revenue growth (TTM) (87.03%) — 6.02%
EPS growth (last fiscal year) (139.47%) 61.59% 30.26%
Revenue growth, 5-year CAGR (5.36%) (15.81%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTMX CYVNY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.36 0.22 4.72
Net debt to EBITDA 5.91 0.31 0.96

Dividend

Metric CTMX CYVNY Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CTMX CYVNY Biotechnology median
Market cap 525.14m 524.83m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack